Mrvan Statement in Support of the Inflation Reduction Act

Washington, DC – Today, Rep. Frank J. Mrvan voted in support of the Inflation Reduction Act of 2022.  

In Congressman Mrvan’s remarks on the House floor, he highlighted the measure’s provisions to lower health care costs for those on Medicare.  Specifically, under this legislation Medicare will negotiate certain prescription drug prices, limit out-of-pocket costs for insulin at $35 per month, and for the first time ever, cap Medicare Part D out-of-pocket drug costs at $2,000. 

Congressman Mrvan stated, “Of particular importance to me are the provisions that finally address the unfair disadvantage our seniors face when deciding between missing a meal or missing a prescription.  This measure represents real progress that provides real relief to seniors.”  

The House approved the measure by a vote of 220 to 207.  As the Senate has approved this measure, it is now submitted to President Biden to be signed into law.  

To watch Congressman Mrvan’s earlier floor remarks on this legislation, click here.

In general, the Inflation Reduction Act contains many provisions that will benefit American consumers, such as lowering health care and energy costs, and promoting initiatives to address climate change.  Additionally, provisions to create equity in the tax code, including the establishment of a minimum tax on companies with more than $1 billion in income, will result in savings from this measure that are expected to exceed $300 billion.   

For additional information on the Inflation Reduction Act, click here and here.

###